Initial Testing of VS-4718, a novel inhibitor of Focal Adhesion Kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program

VS-4718 was tested against the PPTP’s in vitro cell line panel and showed a median relative IC(50) of 1.22 µM. VS-4718 was tested in vivo against the PPTP xenograft models using a dose of 50 mg/kg administered by the oral route twice daily for 21 days. VS-4718 induced significant differences in EFS...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pediatr Blood Cancer
Autores principales: Kurmasheva, Raushan T., Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Maris, John M., Lock, Richard B., Carol, Hernan, Kang, Jiarong Min, Reynolds, C. Patrick, Wu, Jianrong, Houghton, Peter J., Smith, Malcolm A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578428/
https://ncbi.nlm.nih.gov/pubmed/27786412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26304
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares